Hypersensitivity reaction to epirubicin.
A patient with metastatic breast cancer treated with epirubicin (Pharmorubicin) developed a severe urticarial reaction which progressed to ulceration following possible sensitisation to the drug by preceding extravasation.
Cassidy
J
J
CRC Department of Medical Oncology, University of Glasgow, U.K.
Rankin
E M
EM
D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000150:complications; D004342:Drug Hypersensitivity; D015251:Epirubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005119:Extravasation of Diagnostic and Therapeutic Materials; D005260:Female; D006801:Humans; D008875:Middle Aged
D015251:Epirubicin